Form 4 for LH Labcorp
Accepted 2022-09-13 00:00:00 ET · period of report 2022-09-07 · accession 0001127602-22-022354 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-13 | 2022-09-07 | LH | Caveney Brian J | EVP, Pres of Diagnostics | P - Purchase | $231.20 | +44.34 | 14.3K | +0.3% | +$10.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-07 | P | A | 44.34 | $231.20 | 14,281.78 | D | — | — | (F1) Amount includes 65.5254 shares acquired on June 30, 2022 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. |